Similar to our findings, GM-CSF was shown to modulate the immune system to reduce pneumonia by causing a dramatic decrease in immune cell infiltration into the lung during the late stage of infection [32,42]. The gene discussed is CSF2; the disease is susceptibility to pneumonia measurement.